5761-97-7Relevant articles and documents
PHOSPHORUS-CONTAINING COMPOUND AND PREPARATION AND USE THEREOF
-
Paragraph 0190-0191, (2020/05/14)
The present invention provides a phosphorus-containing compound characterized by being a compound represented by the following structure: the compound is a novel immune cell migration inhibitor. The compound has good hydrophilicity and can be developed into eye drops. The compound has a strong inhibitory ability to immune cell migration and can relieve the symptoms of most dry-eye patients.
Stereoselective Synthesis of P-Stereogenic N-Phosphinyl Compounds
Chelouan, Ahmed,Recio, Roco,lvarez, Eleuterio,Khiar, Noureddine,Fernndez, Inmaculada
, p. 255 - 259 (2016/02/14)
A number of P-stereogenic N-phosphinyl compounds were stereoselectively prepared in good yields by a straightforward approach, thanks to the diversified and, up until now, unexplored reactivity of (R)- and (S)-dicyclohexylidene-D-glucose methyl phenyl pho
Cleavage of P=O in the presence of P-N: Aminophosphine oxide reduction with in situ boronation of the PIII product
Kenny, Niall P.,Rajendran, Kamalraj V.,Jennings, Elizabeth V.,Gilheany, Declan G.
supporting information, p. 14210 - 14214 (2013/11/06)
In contrast to tertiary phos-phine oxides, the deoxygenation of aminophosphine oxides is effectively impossible due to the need to break the immensely strong and inert P=O bond in the presence of a relatively weak and more reactive P-N bond. This long-sta
